Torrent Pharmaceuticals, 500420, TORNTPHARM Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,25,825.55
58.80
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,27,710.55
0.86%
14.89

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

5.62
7.55
6.18

EBITDA CAGR (%)

10 Years
5 Years
3 Years

3.10
8.36
5.58

PAT CAGR (%)

10 Years
5 Years
3 Years

0.98
8.83
15.35

P:E (Median)

8 Years
5 Years
3 Years

53.59
58.33
60.05

P:BV (Average)

8 Years
5 Years
3 Years

9.06
10.66
12.41

EV:EBITDA (Average)

8 Years
5 Years
3 Years

22.21
24.75
27.58

Earnings Forecasts:

(Updated: 21-11-2025)

Description 2024 2025 2026 2027
Adj EPS 56.47 72.25 85.78 101.51
P/E Ratio 65.90 51.51 43.38 36.66
Revenue 11317.3 13052 15549.2 17373.1
EBITDA 3720.99 4303.07 5219.02 5924.77
Net Income 1911.25 2450.57 2932.33 3502.01
ROA 12.72 16.52 19.25 19.13
P/B Ratio 16.59 13.96 10.05 8.29
ROE 26.46 28.81 27.35 27.02
FCFF 1731.28 2945.36 2809.33 4107.75
FCFF Yield 1.31 2.24 2.13 3.12
Net Debt 2510.65 1485.75 2517.24 921.58
BVPS 224.28 266.67 370.32 449.14

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 2,762.00 2,434.00 13.48% 2,616.00 2,438.00 7.30% 2,433.00 2,143.00 13.53% 2,377.00 2,123.00 11.96%
Expenses 1,690.00 1,513.00 11.70% 1,637.00 1,539.00 6.37% 1,565.00 1,427.00 9.67% 1,490.00 1,422.00 4.78%
EBITDA 1,072.00 921.00 16.40% 979.00 899.00 8.90% 868.00 716.00 21.23% 887.00 701.00 26.53%
EBIDTM 38.81% 37.84% 37.42% 36.87% 35.68% 33.41% 37.32% 33.02%
Other Income -27.00 -7.00 - -5.00 21.00 - 15.00 76.00 -80.26% 3.00 -11.00 -
Interest 37.00 54.00 -31.48% 45.00 64.00 -29.69% 47.00 67.00 -29.85% 48.00 69.00 -30.43%
Depreciation 189.00 190.00 -0.53% 187.00 189.00 -1.06% 190.00 195.00 -2.56% 191.00 191.00 0.00%
PBT 806.00 670.00 20.30% 742.00 667.00 11.24% 622.00 530.00 17.36% 651.00 430.00 51.40%
Tax 209.00 210.00 -0.48% 191.00 198.00 -3.54% 148.00 120.00 23.33% 166.00 133.00 24.81%
PAT 597.00 460.00 29.78% 551.00 469.00 17.48% 474.00 410.00 15.61% 485.00 297.00 63.30%
PATM 21.61% 18.90% 21.06% 19.24% 19.48% 19.13% 20.40% 13.99%
EPS 17.64 13.59 29.80% 16.28 13.86 17.46% 14.01 12.12 15.59% 14.33 8.78 63.21%

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 3,302.00 2,889.00 14.30% 3,178.00 2,859.00 11.16% 2,959.00 2,745.00 7.80% 2,809.00 2,732.00 2.82%
Expenses 2,219.00 1,950.00 13.79% 2,146.00 1,955.00 9.77% 1,995.00 1,862.00 7.14% 1,895.00 1,863.00 1.72%
EBITDA 1,083.00 939.00 15.34% 1,032.00 904.00 14.16% 964.00 883.00 9.17% 914.00 869.00 5.18%
EBIDTM 32.80% 32.50% 32.47% 31.62% 32.58% 32.17% 32.54% 31.81%
Other Income -27.00 -16.00 - -37.00 24.00 - -18.00 31.00 - 33.00 -33.00 -
Interest 48.00 64.00 -25.00% 56.00 75.00 -25.33% 56.00 80.00 -30.00% 57.00 80.00 -28.75%
Depreciation 204.00 198.00 3.03% 201.00 197.00 2.03% 201.00 203.00 -0.99% 199.00 213.00 -6.57%
PBT 791.00 661.00 19.67% 738.00 656.00 12.50% 665.00 631.00 5.39% 691.00 631.00 9.51%
Tax 200.00 208.00 -3.85% 190.00 199.00 -4.52% 167.00 182.00 -8.24% 188.00 188.00 0.00%
PAT 591.00 453.00 30.46% 548.00 457.00 19.91% 498.00 449.00 10.91% 503.00 443.00 13.54%
PATM 17.90% 15.68% 17.24% 15.98% 16.83% 16.36% 17.91% 16.22%
EPS 17.46 13.38 30.49% 16.19 13.50 19.93% 14.71 13.27 10.85% 14.86 13.09 13.52%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 10,188.00 9,682.44 8,532.90 7,695.20 6,742.32 6,450.57 6,168.44 5,762.48 4,244.43 4,551.45 5,419.59 Net Sales Growth 11.49% 13.47% 10.89% 14.13% 4.52% 4.57% 7.04% 35.77% -6.75% -16.02% Cost Of Goods Sold 2,328.00 2,020.53 1,904.52 1,917.47 1,697.36 1,483.37 1,452.32 1,366.31 977.39 1,224.44 1,037.62 Gross Profit 7,860.00 7,661.91 6,628.38 5,777.73 5,044.96 4,967.20 4,716.12 4,396.17 3,267.04 3,327.01 4,381.97 GP Margin 77.15% 79.13% 77.68% 75.08% 74.83% 77.00% 76.46% 76.29% 76.97% 73.10% 80.85% Total Expenditure 6,382.00 6,106.70 5,643.73 5,230.04 4,641.60 4,258.84 4,251.45 4,149.45 3,337.05 3,424.30 2,778.67 Power & Fuel Cost - 134.25 143.43 153.21 140.00 122.04 126.70 131.49 117.86 107.17 91.17 % Of Sales - 1.39% 1.68% 1.99% 2.08% 1.89% 2.05% 2.28% 2.78% 2.35% 1.68% Employee Cost - 1,636.45 1,450.67 1,251.22 1,097.93 1,097.12 1,061.76 1,014.06 826.07 699.04 572.10 % Of Sales - 16.90% 17.00% 16.26% 16.28% 17.01% 17.21% 17.60% 19.46% 15.36% 10.56% Manufacturing Exp. - 558.41 534.71 518.96 525.94 467.64 510.53 511.80 424.29 483.38 353.59 % Of Sales - 5.77% 6.27% 6.74% 7.80% 7.25% 8.28% 8.88% 10.00% 10.62% 6.52% General & Admin Exp. - 671.08 636.24 543.33 445.93 432.42 428.65 528.34 492.53 397.46 324.98 % Of Sales - 6.93% 7.46% 7.06% 6.61% 6.70% 6.95% 9.17% 11.60% 8.73% 6.00% Selling & Distn. Exp. - 1,002.56 886.54 788.92 673.65 595.84 596.66 539.39 453.50 388.99 366.53 % Of Sales - 10.35% 10.39% 10.25% 9.99% 9.24% 9.67% 9.36% 10.68% 8.55% 6.76% Miscellaneous Exp. - 83.42 87.62 56.93 60.79 60.41 74.83 58.06 45.41 123.82 366.53 % Of Sales - 0.86% 1.03% 0.74% 0.90% 0.94% 1.21% 1.01% 1.07% 2.72% 0.60% EBITDA 3,806.00 3,575.74 2,889.17 2,465.16 2,100.72 2,191.73 1,916.99 1,613.03 907.38 1,127.15 2,640.92 EBITDA Margin 37.36% 36.93% 33.86% 32.04% 31.16% 33.98% 31.08% 27.99% 21.38% 24.76% 48.73% Other Income -14.00 31.53 91.49 81.88 204.21 118.34 236.93 381.96 332.31 299.60 293.49 Interest 177.00 213.40 303.04 297.68 236.29 334.12 430.49 480.97 293.68 202.38 179.83 Depreciation 757.00 759.48 761.05 672.34 602.43 609.84 606.66 578.90 383.88 269.36 213.41 PBT 2,821.00 2,634.39 1,916.57 1,577.02 1,466.21 1,366.11 1,116.77 935.12 562.13 955.01 2,541.17 Tax 714.00 722.12 559.49 525.63 474.76 228.26 178.26 189.70 80.09 100.79 605.36 Tax Rate 25.31% 27.67% 29.19% 33.33% 32.38% 16.71% 15.96% 20.29% 14.25% 10.55% 25.78% PAT 2,107.00 1,888.06 1,357.08 1,051.39 991.45 1,137.85 938.51 745.42 482.04 854.22 1,742.99 PAT before Minority Interest 2,107.00 1,888.06 1,357.08 1,051.39 991.45 1,137.85 938.51 745.42 482.04 854.22 1,742.99 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 20.68% 19.50% 15.90% 13.66% 14.70% 17.64% 15.21% 12.94% 11.36% 18.77% 32.16% PAT Growth 28.79% 39.13% 29.07% 6.05% -12.87% 21.24% 25.90% 54.64% -43.57% -50.99% EPS 62.26 55.79 40.10 31.07 29.30 33.62 27.73 22.03 14.24 25.24 51.51

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 12,248.00 11,516.09 10,727.84 9,620.15 8,508.04 8,004.57 7,939.31 7,672.80 5,949.83 5,815.69 6,666.85 Net Sales Growth 9.11% 7.35% 11.51% 13.07% 6.29% 0.82% 3.47% 28.96% 2.31% -12.77% Cost Of Goods Sold 2,978.00 2,555.63 2,458.95 2,513.20 2,230.75 1,960.12 1,981.79 2,041.26 1,535.17 1,629.66 1,432.13 Gross Profit 9,270.00 8,960.46 8,268.89 7,106.95 6,277.29 6,044.45 5,957.52 5,631.54 4,414.66 4,186.03 5,234.72 GP Margin 75.69% 77.81% 77.08% 73.88% 73.78% 75.51% 75.04% 73.40% 74.20% 71.98% 78.52% Total Expenditure 8,255.00 7,811.74 7,364.25 6,796.18 6,076.77 5,524.49 5,768.95 5,696.31 4,600.58 4,438.42 3,937.05 Power & Fuel Cost - 137.34 145.20 155.28 144.19 122.94 128.19 132.46 118.77 107.98 92.59 % Of Sales - 1.19% 1.35% 1.61% 1.69% 1.54% 1.61% 1.73% 2.00% 1.86% 1.39% Employee Cost - 2,203.37 1,984.40 1,677.69 1,526.45 1,439.62 1,429.04 1,403.79 1,135.25 993.41 842.35 % Of Sales - 19.13% 18.50% 17.44% 17.94% 17.98% 18.00% 18.30% 19.08% 17.08% 12.63% Manufacturing Exp. - 594.29 570.58 570.79 591.13 550.92 544.11 558.84 457.58 502.16 353.45 % Of Sales - 5.16% 5.32% 5.93% 6.95% 6.88% 6.85% 7.28% 7.69% 8.63% 5.30% General & Admin Exp. - 960.60 980.72 775.30 637.65 633.48 801.98 763.90 677.71 578.05 637.92 % Of Sales - 8.34% 9.14% 8.06% 7.49% 7.91% 10.10% 9.96% 11.39% 9.94% 9.57% Selling & Distn. Exp. - 1,260.67 1,129.68 1,026.99 884.91 742.63 807.39 738.03 641.30 567.70 547.05 % Of Sales - 10.95% 10.53% 10.68% 10.40% 9.28% 10.17% 9.62% 10.78% 9.76% 8.21% Miscellaneous Exp. - 99.84 94.72 76.93 61.69 74.78 76.45 58.03 34.80 59.46 547.05 % Of Sales - 0.87% 0.88% 0.80% 0.73% 0.93% 0.96% 0.76% 0.58% 1.02% 0.47% EBITDA 3,993.00 3,704.35 3,363.59 2,823.97 2,431.27 2,480.08 2,170.36 1,976.49 1,349.25 1,377.27 2,729.80 EBITDA Margin 32.60% 32.17% 31.35% 29.35% 28.58% 30.98% 27.34% 25.76% 22.68% 23.68% 40.95% Other Income -49.00 39.91 61.97 63.22 196.56 56.91 121.30 63.62 298.84 223.30 228.80 Interest 217.00 252.31 353.56 333.44 255.06 352.94 450.71 503.75 308.48 205.56 183.98 Depreciation 805.00 794.93 808.27 706.59 662.16 657.79 654.38 617.69 408.60 306.92 237.55 PBT 2,885.00 2,697.02 2,263.73 1,847.16 1,710.61 1,526.26 1,186.57 918.67 931.01 1,088.09 2,537.07 Tax 745.00 761.56 695.73 601.93 448.73 274.38 161.85 125.35 252.87 154.51 610.17 Tax Rate 25.82% 28.49% 29.58% 32.59% 36.60% 17.98% 13.64% 22.32% 27.16% 14.20% 26.04% PAT 2,140.00 1,911.25 1,656.38 1,245.23 777.18 1,251.88 1,024.72 436.28 678.11 933.55 1,733.24 PAT before Minority Interest 2,140.00 1,911.25 1,656.38 1,245.23 777.18 1,251.88 1,024.72 436.31 678.14 933.58 1,733.27 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.03 -0.03 -0.03 -0.03 PAT Margin 17.47% 16.60% 15.44% 12.94% 9.13% 15.64% 12.91% 5.69% 11.40% 16.05% 26.00% PAT Growth 18.76% 15.39% 33.02% 60.22% -37.92% 22.17% 134.88% -35.66% -27.36% -46.14% EPS 63.24 56.48 48.95 36.80 22.97 36.99 30.28 12.89 20.04 27.59 51.22

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 7,592.50 6,828.76 6,455.96 6,345.42 6,030.10 5,120.97 5,015.27 4,556.49 4,453.71 3,707.31 Share Capital 169.23 169.23 169.23 84.62 84.62 84.62 84.62 84.62 84.62 84.62 Total Reserves 7,423.27 6,659.53 6,286.73 6,260.80 5,945.48 5,036.35 4,930.65 4,471.87 4,369.09 3,622.69 Non-Current Liabilities 2,269.63 2,559.23 3,006.82 2,383.78 3,116.81 3,308.26 3,924.18 4,275.21 2,442.69 2,079.28 Secured Loans 1,020.59 1,603.78 2,331.78 1,971.60 2,941.07 3,138.43 3,736.88 4,105.31 2,197.48 1,773.65 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 1.56 3.11 6.15 11.26 10.62 Long Term Provisions 337.78 282.15 244.54 210.83 193.93 176.72 163.77 149.10 126.34 114.69 Current Liabilities 2,979.63 2,988.60 3,409.15 2,423.36 2,585.80 3,387.48 3,087.82 2,987.55 1,154.51 1,501.95 Trade Payables 767.11 759.76 610.63 624.21 648.05 682.07 582.33 775.72 547.95 665.17 Other Current Liabilities 990.51 827.90 1,450.12 1,278.84 1,420.54 1,822.33 1,694.82 1,091.57 551.16 789.83 Short Term Borrowings 941.88 1,200.00 1,197.77 399.97 410.38 789.31 726.60 1,040.20 0.00 0.00 Short Term Provisions 280.13 200.94 150.63 120.34 106.83 93.77 84.07 80.06 55.40 46.95 Total Liabilities 12,841.76 12,376.59 12,871.93 11,152.56 11,732.71 11,816.71 12,027.27 11,819.25 8,050.91 7,288.54 Net Block 7,554.04 7,985.92 7,971.85 6,251.25 6,741.24 7,197.50 7,425.15 7,428.53 3,523.49 2,681.39 Gross Block 13,300.97 12,999.81 12,366.86 10,002.35 9,952.74 9,805.61 9,465.64 8,905.10 4,634.19 3,531.56 Accumulated Depreciation 5,746.93 5,013.89 4,395.01 3,751.10 3,211.50 2,608.11 2,040.49 1,476.57 1,110.70 850.17 Non Current Assets 8,492.96 8,635.53 8,944.85 7,092.51 7,590.83 7,997.45 8,278.32 8,180.11 4,505.33 4,150.74 Capital Work in Progress 401.84 226.23 697.93 567.50 588.11 536.41 497.58 447.38 473.07 983.69 Non Current Investment 410.52 322.27 205.12 183.66 174.87 134.87 134.87 149.83 148.41 153.91 Long Term Loans & Adv. 121.45 95.24 68.42 65.30 75.61 100.91 93.35 93.32 237.96 246.50 Other Non Current Assets 5.11 5.87 1.53 24.80 11.00 27.76 127.37 61.05 122.40 85.25 Current Assets 4,348.80 3,741.06 3,927.08 3,933.40 4,141.88 3,819.26 3,748.95 3,639.14 3,545.58 3,137.80 Current Investments 112.21 141.04 156.09 183.98 139.05 0.02 351.35 475.22 787.43 764.24 Inventories 1,560.83 1,565.59 1,602.23 1,797.11 1,911.74 1,507.76 1,358.30 1,299.40 1,032.29 970.13 Sundry Debtors 2,170.79 1,571.94 1,729.44 1,541.35 1,544.26 1,508.94 1,356.01 1,108.04 1,018.47 911.50 Cash & Bank 109.74 108.76 147.61 69.46 66.42 390.95 237.84 57.09 78.22 82.37 Other Current Assets 395.23 231.24 156.52 232.90 480.41 411.59 445.45 699.39 629.17 409.56 Short Term Loans & Adv. 164.19 122.49 135.19 108.60 41.24 62.74 86.19 182.76 110.06 119.86 Net Current Assets 1,369.17 752.46 517.93 1,510.04 1,556.08 431.78 661.13 651.59 2,391.07 1,635.85 Total Assets 12,841.76 12,376.59 12,871.93 11,025.91 11,732.71 11,816.71 12,027.27 11,819.25 8,050.91 7,288.54

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 7,590.69 6,856.15 6,198.07 5,952.95 5,837.17 4,823.22 4,724.35 4,622.19 4,350.13 3,494.10 Share Capital 169.23 169.23 169.23 84.62 84.62 84.62 84.62 84.62 84.62 84.62 Total Reserves 7,421.46 6,686.92 6,028.84 5,868.33 5,752.55 4,738.60 4,639.73 4,537.57 4,265.51 3,409.48 Non-Current Liabilities 2,087.71 2,224.05 2,822.81 2,238.15 2,924.20 3,299.15 3,861.40 4,142.42 2,303.33 1,994.65 Secured Loans 1,191.75 1,603.78 2,496.22 2,123.22 2,941.07 3,302.29 3,909.81 4,105.31 2,229.57 1,839.46 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 1.56 3.11 6.15 11.26 10.62 Long Term Provisions 501.27 444.69 393.06 368.74 369.62 338.34 288.52 286.66 263.04 246.36 Current Liabilities 4,717.19 5,425.25 5,447.30 4,415.09 4,891.62 5,454.16 5,165.32 5,202.17 2,738.26 3,285.48 Trade Payables 1,820.02 2,089.32 1,678.80 1,674.44 2,066.81 2,048.81 2,096.74 2,048.24 1,749.32 2,260.22 Other Current Liabilities 1,143.50 1,130.15 1,578.41 1,365.10 1,635.36 1,860.80 1,641.26 1,151.68 687.14 822.28 Short Term Borrowings 1,249.97 1,637.71 1,765.07 923.04 704.40 1,090.85 934.11 1,625.60 0.00 3.32 Short Term Provisions 503.70 568.07 425.02 452.51 485.05 453.70 493.21 376.65 301.80 199.66 Total Liabilities 14,395.59 14,505.45 14,468.18 12,606.19 13,652.99 13,576.53 13,751.07 13,967.30 9,392.21 8,774.69 Net Block 7,946.90 8,138.11 8,121.45 6,422.65 7,064.63 7,533.12 7,747.71 7,854.68 3,688.44 2,859.08 Gross Block 14,041.34 13,484.57 12,811.62 10,728.19 10,511.53 10,334.13 9,935.43 9,449.48 4,909.80 3,793.53 Accumulated Depreciation 6,094.44 5,346.46 4,690.17 4,305.54 3,446.90 2,801.01 2,187.72 1,594.80 1,221.36 934.45 Non Current Assets 8,773.02 8,893.97 9,139.00 7,311.54 8,129.77 8,595.61 8,713.53 8,704.89 4,512.74 4,085.66 Capital Work in Progress 478.14 360.51 765.40 629.82 889.38 711.93 617.12 646.94 519.49 1,041.58 Non Current Investment 43.57 31.80 42.70 42.33 42.09 2.09 2.09 0.09 0.09 0.09 Long Term Loans & Adv. 294.29 349.34 181.04 166.55 96.84 222.19 150.58 130.96 182.32 99.66 Other Non Current Assets 10.12 14.21 28.41 50.19 36.83 126.28 196.03 72.22 122.40 85.25 Current Assets 5,622.57 5,611.48 5,313.72 5,164.99 5,523.22 4,980.92 5,037.54 5,262.41 4,879.47 4,689.03 Current Investments 112.21 141.04 156.09 183.98 139.05 0.02 351.35 492.27 803.55 779.59 Inventories 2,541.25 2,279.07 2,229.64 2,462.32 2,681.20 2,148.22 1,935.15 1,966.30 1,559.15 1,357.98 Sundry Debtors 1,866.45 1,844.30 1,943.82 1,632.48 1,523.37 1,649.34 1,435.71 1,253.45 950.89 1,445.09 Cash & Bank 579.46 839.04 571.46 403.41 603.50 666.65 816.04 867.23 893.72 647.03 Other Current Assets 523.20 327.99 246.89 331.62 576.10 516.69 499.29 683.16 672.16 459.34 Short Term Loans & Adv. 199.58 180.04 165.82 151.18 63.41 73.48 93.46 95.39 82.62 90.18 Net Current Assets 905.38 186.23 -133.58 749.90 631.60 -473.24 -127.78 60.24 2,141.21 1,403.55 Total Assets 14,395.59 14,505.45 14,452.72 12,476.53 13,652.99 13,576.53 13,751.07 13,967.30 9,392.21 8,774.69

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 2,574.50 2,893.10 2,265.41 2,140.10 1,572.89 1,579.90 1,231.83 929.14 679.38 2,403.00 PBT 2,610.18 1,916.57 1,577.02 1,466.21 1,366.11 1,116.77 935.12 562.13 955.01 2,348.35 Adjustment 969.50 957.61 990.49 827.91 884.80 857.08 820.78 622.51 369.49 480.67 Changes in Working Capital -515.07 343.60 -29.64 86.25 -468.12 -187.25 -315.89 -123.22 -389.94 63.75 Cash after chg. in Working capital 3,064.61 3,217.78 2,537.87 2,380.37 1,782.79 1,786.60 1,440.01 1,061.42 934.56 2,892.77 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -490.11 -324.68 -272.46 -240.27 -209.90 -206.70 -208.18 -132.28 -255.18 -489.77 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -470.09 -296.07 -2,384.07 -159.70 -316.28 269.43 -373.33 -4,206.99 -532.60 -586.20 Net Fixed Assets -476.77 -161.25 -2,494.94 -29.00 -198.83 -378.80 -610.74 -4,245.22 -592.01 -471.42 Net Investments -59.42 -102.10 6.43 -53.72 -179.03 351.33 138.83 310.79 -17.69 -484.32 Others 66.10 -32.72 104.44 -76.98 61.58 296.90 98.58 -272.56 77.10 369.54 Cash from Financing Activity -2,104.46 -2,577.57 80.74 -1,977.27 -1,581.20 -1,555.48 -927.58 2,928.72 -131.25 -1,325.82 Net Cash Inflow / Outflow -0.05 19.46 -37.92 3.13 -324.59 293.85 -69.08 -349.13 15.53 490.98 Opening Cash & Equivalents 104.86 85.40 65.00 61.87 386.46 92.61 512.99 862.12 846.59 353.83 Closing Cash & Equivalent 104.81 104.86 85.40 65.00 61.87 386.46 443.91 512.99 862.12 846.59

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 2,585.11 3,266.08 2,368.13 1,802.99 2,005.35 1,392.91 1,798.08 894.15 1,008.84 2,742.12 PBT 2,672.81 2,352.11 1,847.16 1,225.91 1,526.26 1,186.57 561.66 931.01 1,088.09 2,343.44 Adjustment 996.05 993.99 937.24 1,349.95 992.84 876.21 1,418.19 606.92 430.27 552.44 Changes in Working Capital -480.93 418.08 -18.20 -351.85 -338.25 -385.83 99.39 -360.16 -125.21 423.58 Cash after chg. in Working capital 3,187.93 3,764.18 2,766.20 2,224.01 2,180.85 1,676.95 2,079.24 1,177.77 1,393.15 3,319.46 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -602.82 -498.10 -398.07 -421.02 -175.50 -284.04 -281.16 -283.62 -384.31 -577.34 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -540.05 -167.90 -2,415.31 -196.63 -449.42 198.61 -241.28 -4,706.95 -786.91 -837.85 Net Fixed Assets -476.77 -161.25 -2,494.94 -29.00 -198.83 -378.80 -610.74 -4,245.22 -592.01 -471.42 Net Investments -59.42 -102.10 6.43 -53.72 -179.03 351.33 138.83 310.79 -17.69 -484.32 Others -3.86 95.45 73.20 -113.91 -71.56 226.08 230.63 -772.52 -177.21 117.89 Cash from Financing Activity -2,297.99 -2,779.64 77.36 -1,781.05 -1,650.79 -1,549.04 -1,314.45 3,417.39 -192.91 -1,435.15 Net Cash Inflow / Outflow -252.93 318.54 30.18 -174.69 -94.86 42.48 242.35 -395.41 29.02 469.12 Opening Cash & Equivalents 835.14 508.53 398.40 572.56 661.82 588.76 702.04 1,067.57 1,049.86 612.38 Closing Cash & Equivalent 573.48 835.14 508.53 398.40 572.56 661.82 940.06 702.04 1,067.57 1,049.86

Financial Ratios

Consolidated /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 224.32 201.76 190.75 187.47 178.15 302.59 296.34 269.23 263.16 219.06 ROA 14.97% 10.75% 8.75% 8.66% 9.66% 7.87% 6.25% 4.85% 11.14% 25.29% ROE 26.18% 20.43% 16.43% 16.02% 20.41% 18.52% 15.58% 10.70% 20.93% 54.36% ROCE 27.82% 20.96% 18.10% 16.94% 16.30% 14.68% 13.46% 9.89% 18.01% 45.21% Fixed Asset Turnover 0.75 0.69 0.70 0.69 0.66 0.65 0.63 0.64 1.12 1.57 Receivable days 69.04 69.19 76.09 82.04 85.05 83.57 77.19 90.16 76.69 70.22 Inventory Days 57.67 66.39 79.08 98.61 95.25 83.60 83.26 98.86 79.57 58.76 Payable days 137.91 131.32 117.53 136.79 163.65 52.42 59.32 72.18 69.01 88.12 Cash Conversion Cycle -11.21 4.26 37.63 43.85 16.66 114.75 101.13 116.84 87.25 40.85 Total Debt/Equity 0.34 0.49 0.71 0.53 0.73 1.04 1.12 1.28 0.55 0.61 Interest Cover 13.23 7.32 6.30 7.21 5.09 3.59 2.94 2.91 5.72 14.06

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 224.27 202.57 183.13 175.87 172.45 284.99 279.15 273.11 257.04 206.46 ROA 13.23% 11.43% 9.20% 5.92% 9.20% 7.50% 3.15% 5.81% 10.28% 20.89% ROE 26.46% 25.38% 20.50% 13.18% 23.49% 21.47% 9.34% 15.12% 23.80% 57.92% ROCE 27.32% 24.28% 20.32% 14.35% 17.62% 15.28% 9.75% 13.81% 20.36% 45.63% Fixed Asset Turnover 1.22 1.27 1.39 1.43 1.43 1.48 1.50 1.57 1.35 1.82 Receivable days 40.18 41.38 39.99 37.86 38.92 37.65 33.78 35.74 74.66 82.76 Inventory Days 52.20 49.26 52.47 61.71 59.24 49.84 49.01 57.16 90.90 66.19 Payable days 279.17 279.66 243.50 306.08 383.19 133.47 139.05 150.99 171.27 204.35 Cash Conversion Cycle -186.79 -189.03 -151.04 -206.50 -285.04 -45.98 -56.26 -58.09 -5.72 -55.41 Total Debt/Equity 0.40 0.57 0.85 0.68 0.83 1.21 1.28 1.40 0.58 0.67 Interest Cover 11.59 7.65 6.54 5.81 5.32 3.63 2.11 4.02 6.29 13.74

Top Investors:

nps trust

hdfc mutual fund - hdfc pharma and healthcare fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Torrent Pharmaceuticals reports 30% rise in Q2 consolidated net profit
10th Nov 2025, 14:41 PM

The consolidated total income of the company increased by 13.99% at Rs 3,275 crore for Q2FY26
Read More
Torrent Pharma - Quarterly Results
8th Nov 2025, 00:00 AM

Read More
Torrent Pharmaceuticals enters into agreement to subscribe 26% stake in Torrent Urja 27
10th Sep 2025, 17:22 PM

The said acquisition is expected to be completed in 18 to 20 months
Read More

Torrent Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Global

BSE: 500420 | NSE: TORNTPHARM

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Torrent Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Global

BSE: 500420 | NSE: TORNTPHARM

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: